NFE2L2 and cancer: Due to the “double-edged sword” nature of the NRF2 pathway, it has been considered as an important therapeutic target in many cancers, and the inhibition of NRF2 overexpression could pave the way for inhibiting tumor growth and drug resistance [35, 36].